Abstract:Qiuning Wang, 1, &ast Weiying Chen, 2, &ast Xuefeng Yang, 3 Ying Song, 4 Xiaowei Sun, 5 Guizhou Tao, 6 Hong Wang, 7 Nan Zhao, 7 Yue Huang, 1 Erqing Chai, 8 Futian Tang 9 1 Department of Pharmacology, Jinzhou Medical University, Jinzhou, Liaoning Province, People's Republic of China; 2 Department of Drug Quality Analysis, Jiuquan Drug Inspection and Testing Center, Jiuquan, Gansu Province, People's Republic of China; 3 Department of Physiology, Jinzhou Medical University, Jinzhou, Liaoning Province, People's Republic of China; 4 Cardiovascular Laboratory, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People's Republic of China; 5 Department of Neurosurgery, China Resources Liaojian Group, General Hospital of Fuxin Mining Group (10th Clinical College of China Medical University), Fuxin, Liaoning Province, People's Republic of China; 6 Internal Medicine-Cardiovascular Department, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People's Republic of China; 7 Allergy and Clinical Immunology Center, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People's Republic of China; 8 Neurointerventional Department, Emergency General Hospital, Beijing, People's Republic of China; 9 Department of Cardiovascular Disease and Key Laboratory of Digestive System Tumor of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Futian Tang, Department of Cardiovascular Disease and Key Laboratory of Digestive System Tumor of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu Province, People's Republic of China, Email Erqing Chai, Neurointerventional Department, Emergency General Hospital, Beijing, People's Republic of China, Email Introduction: Astragaloside IV (AS-IV) is one of the main active components isolated from the traditional Chinese medicinal herb, Astragalus membranaceus . The present study was designed to investigate whether the regulation of microRNA-1 (miR-1)-mediated inflammation and autophagy contributes to the protective effect of AS-IV against cardiac dysfunction in rats treated with lipopolysaccharides (LPS). Methods: Animal model of cardiac dysfunction in rats or cellular model of injured H9c2 heart cell line was established by using LPS. Echocardiography, electron microscopy, enzyme-linked immunosorbent assay, immunofluorescence, quantitative RT-PCR, and Western blotting were used to determine the cardiac function and expression of inflammation- and autophagy-related proteins at both the mRNA and protein levels. Results: LPS caused cardiac dysfunction in rats or injury in H9c2 cells and induced inflammation and autophagy. Compared with LPS treatment, AS-IV treatment attenuated cardiac dysfunction or cell injury, accompanied by inhibition of inflammation and autophagy. However, the miR-1 mimics partly abolished the effects of AS-IV. In addition, the effect of the miR-1 inhibitor was similar to that of AS-IV in the LPS model. Further analyses showed that AS-IV treatment decreased the mRNA expression of miR-1 in the heart tissue of rats and H9c2 cells treated with LPS. Conclusion: These results suggest that AS-IV attenuated cardiac dysfunction caused by LPS by inhibiting miR-1-mediated inflammation and autophagy, thereby providing a novel mechanism for the protection against cardiac diseases. Keywords: lipopolysaccharides, astragaloside IV, cardiac dysfunction, inflammation, autophagy, miRNA-1 Astragali Radix is prepared from the roots of Astragalus membranaceus (Fisch.) Bunge. 1 As a kind of traditional Chinese medicine, Astragali Radix has a wide range of pharmacological effects, especially on cardiovascular diseases, such as coronary heart disease, 2 heart failure, 3 viral myocarditis, 4 and hypertension. 5 Astragaloside IV (AS-IV), one of the main active ingredients in A. membranaceus , exerts various protective effects against cardiovascular diseases, such as preventing the endothelial dysfunction of the aortas in streptozotocin-induced diabetic mice, 6 ameliorating lead-related cognitive impairments in mice, 7 attenuating hypoxia-induced pulmonary vascular remodeling, 8 and restoring myocardial infarction-induced cardiac dysfunction. 9 Many studies have shown that several mechanisms contribute to the protective effects -Abstract Truncated-

Significance of Astragaloside IV from the Roots of Astragalus mongholicus as an Acetylcholinesterase Inhibitor—From the Computational and Biomimetic Analyses to the In Vitro and In Vivo Studies of Safety

Surface-Enhanced Raman Spectroscopy Analysis of Astragalus Saponins and Identification of Metabolites After Oral Administration in Rats by Ultrahigh-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Analysis

Astraoleanosides E–P, oleanane-type triterpenoid saponins from the aerial parts of Astragalus membranaceus Bunge and their β-glucuronidase inhibitory activity

Anti-Cholinergic Effects of the Phenolic Extract from the Astragalus crenatus Plant: A Computational and Network Pharmacology Study

Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102)

Ultrasound-Assisted Extraction, LC-MS/MS Analysis, Anticholinesterase, and Antioxidant Activities of Valuable Natural Metabolites from Astragalus armatus Willd.: In Silico Molecular Docking and In Vitro Enzymatic Studies

Effect of Astragaloside IV on Hepatic Glucose‐regulating Enzymes in Diabetic Mice Induced by a High‐fat Diet and Streptozotocin

Astragaloside IV inhibits proliferation and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro.

Molecular Interaction Studies of Acetylcholinesterase with Potential Acetylcholinesterase Inhibitors from the Root of Rhodiola Crenulata Using Molecular Docking and Isothermal Titration Calorimetry Methods.

Pharmacological Effects of Astragaloside IV: A Review

[Inhibitory Effects of Astragaloside IV on Cytochrome P450 Enzyme of Rat Liver Microsomes].

A Simple and Sensitive LC–MS/MS Approach for Simultaneous Quantification of Six Bioactive Compounds in Rats Following Oral Administration of Aqueous Extract and Ultrafine Powder of Astragalus Propinquus: Application to a Comparative Pharmacokinetic Study

Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study

In Silico Studies with In Vivo Analysis and Post Mortem ADME-Tox Profiling in Mice

Influence of extraction solvents on the chemical constituents and biological activities of Astragalus aduncus from Turkey flora: In vitro and in silico insights

Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells

A solid preparation of phytochemicals: improvement of the solubility and bioavailability of astragaloside IV based on β-cyclodextrin microencapsulation

Transport and Bioavailability Studies of Astragaloside IV, an Active Ingredient in Radix Astragali

Immunomodulatory Effect of a New Ingredients Group Extracted from Astragalus Through Membrane Separation Technique

Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats

Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression